JAZZ

Jazz Pharmaceuticals Stock Price

144.10
-1.53 (-1.05%)
Upgrade to Real-Time
Afterhours (Closed)
144.10
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Jazz Pharmaceuticals PLC JAZZ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.53 -1.05% 144.10 20:00:00
Close Price Low Price High Price Open Price Previous Close
144.10 143.03 146.38 145.50 145.63
Bid Price Ask Price Spread News
135.00 144.74 9.74 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,005 563,220 $ 144.73 $ 81,514,746 799,981 86.88 - 156.265
Last Trade Time Type Quantity Stock Price Currency
17:47:53 formt 317 $ 144.10 USD

Jazz Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.99B 55.46M 54.05M $ 2.16B $ 39.78M 9.10 63.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 36.04k 5.60%

more financials information »

Jazz Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JAZZ Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week152.51152.51143.03147.77360,342-8.41-5.51%
1 Month142.47156.265140.28149.24508,0361.631.14%
3 Months125.87156.265119.0771139.35720,97718.2314.48%
6 Months111.00156.265101.81125.35686,15433.1029.82%
1 Year127.10156.26586.88125.89639,28017.0013.38%
3 Years134.35184.0086.88137.30563,1949.757.26%
5 Years135.86184.0086.88136.78570,1898.246.07%

Jazz Pharmaceuticals Description

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology. Jazz's product portfolio includes its lead drug, Xyrem, for narcolepsy, Sunosi for improving wakefulness in patients with excessive daytime sleepiness, Defitelio for severe veno-occlusive disease after stem cell transplant, Vyxeos for acute myeloid leukemia, and Zepzelca for small cell lung cancer.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.